Autism Drug Push Stumbles as GSK Pulls Application

Federal health officials last fall touted a new treatment for autism: leucovorin, a derivative of Vitamin B9 commonly used during cancer treatment. But the drugmaker, GSK, this week asked the Food and Drug Administration to pull its application.